pandora-id

1). Abubakar I, Zumla A. Universal health coverage for refugees and migrants in the twenty-first century. BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0. PMID: 30497477

2). Zumla A, Abubakar I. Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants. BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0. PMID: 30497477

3). Edwards SJL, Norell CH, Illari P, Clarke B, Neuhaus CP. A Radical Approach to Ebola: Saving Humans and Other Animals. Am J Bioeth. 2018;18(10):35-42

4) Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F

Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo — Progress, obstacles and challenges in HIV/ AIDS health services

Int J Infect Dis. 2018;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17. PMID: 30342250

5). Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, Chakaya J, Zumla A, Ippolito G Tuberculin skin test – Outdated or still useful for Latent TB infection screening? Int J Infect Dis. 2019; 80S:S20-S22 DOI: 10.1016/j.ijid.2019.01.048. PMID:30738186

6). Honeyborne I, Lipman M, Zumla A, McHugh TD The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world? Int J Infect Dis. 2019; Mar;80S:S23-S28. doi: 10.1016/j.ijid.2019.02.006. Epub 2019 Feb 15. PMID: 30776547

7). Kock RA, Haider N, Mboera LEG, Zumla A. A One-Health lens for anthrax. Lancet Planet Health. 2019 Jul;3(7):e285-e286. doi: 10.1016/S2542-5196(19)30111-1. PMID: 31326067

8). Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.  Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis. 2019; Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review. PMID: 30453097

9). Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M. Latent TB Infection (LTBI) – Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. Int J Infect Dis. 2019 Mar; 80S:S58-S61. doi: 10.1016/j.ijid.2019.02.035. Epub 2019 Feb 26. PMID: 30822547

10). Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M. Improving treatment outcomes for MDR-TB — Novel host-directed therapies and personalised medicine of the future. Int J Infect Dis. 2019; 80S: Mar;80S:S62-S67. doi: 10.1016/j.ijid.2019.01.039. Epub 2019 Jan 24. PMID:30685590

11) Tembo J, Simulundu E, Changula K, Handley D, Gilbert M, Chilufya M, Asogun D, Ansumana R, Kapata N, Ntoumi F, Ippolito G, Zumla A, Bates M. Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease. Expert Rev Mol Diagn. 2019 Apr;19(4):325-340. doi: 10.1080/14737159.2019.1595592. Epub 2019 Apr 5. PMID: 30916590

12). Muneer A, Macrae B, Krishnamoorthy S, Zumla A. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-598. doi: 10.1038/s41585-019-0228-9. PMID: 31548730

13). Lanini S, Ioannidis JPA, Vairo F, Pletschette M, Portella G, Di Bari V, Mammone A, Pisapia R, Merler S, Nguhuni B, Langer M, Di Caro A, Edwards SJL, Petrosillo N, Zumla A, Ippolito G. Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.Lancet Infect Dis. 2019 Aug 23. pii: S1473-3099(19)30284-1. doi: 10.1016/S1473-3099(19)30284-1. PMID: 31451421

14). Lalle E, Biava M, Nicastri E, Colavita F, Di Caro A, Vairo F, Lanini S, Castilletti C, Langer M, Zumla A, Kobinger G, Capobianchi MR, Ippolito G. Pulmonary Involvement during the Ebola Virus Disease. Viruses. 2019 Aug 24;11(9). pii: E780. doi: 10.3390/v11090780. PMID: 3145059

15). Zumla A, Memish ZA. Risk of antibiotic resistant meningococcal infections in Hajj pilgrims. BMJ. 2019 Aug 23;366:l5260. doi: 10.1136/bmj.l5260. PMID: 31444169.

16). Perlman S, Azhar EI, Memish ZA, Hui DS, Zumla A. Confronting the persisting threat of the Middle East respiratory syndrome to global health security.

Lancet Infect Dis. 2019 Jul 3. pii: S1473-3099(19)30347-0. doi: 10.1016/S1473-3099(19)30347-0. PMID: 31279728

17). Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, Zumla A. Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events. Lancet. 2019 May 18;393(10185):2073-2084. doi: 10.1016/S0140-6736(19)30501-X. PMID: 31106753

18). Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya - Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention.

Infect Dis Clin North Am. 2019 Dec;33(4):1003-1025. doi: 10.1016/j.idc.2019.08.006. PMID: 31668189.

19). Nicastri E, Kobinger G, Vairo F, Montaldo C, Mboera L, Ansunama R, Zumla A, Ippolito G. Ebola Virus Disease - Epidemiology, Clinical Features, Management, and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):953-976. doi: 10.1016/j.idc.2019.08.005. PMID: 31668200

20). Iannetta M, Di Caro A, Nicastri E, Vairo F, Masanja H, Kobinger G, Mirazimi A, Ntoumi F, Zumla A, Ippolito G. Viral Hemorrhagic Fevers Other than Ebola and Lassa. Infect Dis Clin N Am. 2019; 33: 977–10022019 Dec;33(4):977-1002. doi: 10.1016/j.idc.2019.08.003. PMID: 31668201

21). Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral Hepatitis - Etiology, Epidemiology, Transmission, Diagnostics, Treatment and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1045-1062.doi:10.1016/j.idc.2019.08.004. PMID:31668190

22). Asogun DA, Günther S, Akpede GO, Ihekweazu C, Zumla A. Lassa Fever - Epidemiology, Clinical Features, Diagnosis, Management and Prevention Infect Dis Clin N Am 2019; Dec;33(4):933-951. doi: 10.1016/j.idc.2019.08.002. PMID: 31668199

23). Zumla A, Hui DSC. Emerging and Re-emerging Infectious Diseases - Global Overview. Infect Dis Clin North Am. 2019 Dec;33(4):xiii-xix. doi: 10.1016/j.idc.2019.09.001. PMID: 31668202

24). Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A. The Middle East Respiratory Syndrome (MERS). Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001. PMID: 31668197

25). Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect Dis Clin North Am. 2019 Dec;33(4):869-889. doi: 10.1016/j.idc.2019.07.001. PMID: 31668196

26). Tiberi S, Zumla A, Migliori GB. Multidrug and Extensively Drug-resistant Tuberculosis - Epidemiology, Clinical Features, Management and Treatment. Infect Dis Clin North Am. 2019 Dec;33(4):1063-1085. doi: 10.1016/j.idc.2019.09.002. PMID: 31668191

27). Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, Zumla A. Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention. Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043. doi: 10.1016/j.idc.2019.03.001. Epub 2019 Apr 11. PMID: 30981594

28). Mikounou VL, Nguekeng Tsague B, Ntoumi F, Vouvoungui C, Charles Kobawila S. 2019. High prevalence of norovirus and rotavirus co-infection in children with acute gastroenteritis hospitalized in Brazzaville, Republic of Congo. Tropical Medicine and International Health. 2019 Oct 18. doi: 10.1111/tmi.13317

29). Mikounou Louya V, Vouvoungui C, Koukouikila-Koussounda F, Veas F, Kobawila SC, Ntoumi F. Molecular characterization of norovirus infection responsible for acute diarrhea in Congolese hospitalized children under five years old in Brazzaville, Republic of Congo. Int J Infect Dis. 2019 Aug 2;88:41-48. doi: 10.1016/j.ijid.2019.07.034. [Epub ahead of print] PMID: 31382046

30). Ntoumi F. Supporting female scientists in Africa. Lancet. 2019 Jun 1;393(10187):2196. doi: 10.1016/S0140-6736(19)31105-5. PMID: 31162075

31). Peko SM, Ntoumi F, Vouvoungui C, Nderu D, Kobawila SC, Velavan TP, Koukouikila-Koussounda F. Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo. Int J Infect Dis. 2019 Aug;85:49-53. doi: 10.1016/j.ijid.2019.04.035. Epub 2019 May 9. PMID: 31078747

32). Mbouamboua Y, Koukouikila-Koussounda F, Ntoumi F, Adukpo S, Kombo M, Vouvoungui C, van Helden J, Kobawila SC. Sub-microscopic Plasmodium falciparum infections in matched peripheral, placental and umbilical cord blood samples from asymptomatic Congolese women at delivery. Acta Trop. 2019 May;193:142-147. doi: 10.1016/j.actatropica.2019.03.001. PMID: 30836060

33). Gampio Gueye NS, Peko SM, Nderu D, Koukouikila-Koussounda F, Vouvoungui C, Kobawila SC, Velavan TP, Ntoumi F. 2019. An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo. Malaria Journal. 2019 Feb 28;18(1):57. doi: 10.1186/s12936-019-2688-z. PMID: 30819192

34). Peko SM, Gueye NSG, Vouvoungui C, Koukouikila-Koussounda F, Kobawila SC, Nderu D, Velavan TP, Ntoumi F. Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection. Int J Infect Dis. 2019 May;82:111-116. doi: 10.1016/j.ijid.2019.02.025. Epub 2019 Feb 25. PMID: 30818046